Literature DB >> 33490960

A Rare Case of Metastatic Esophageal Adenocarcinoma Presenting as an Isolated Cerebellar Lesion 5 Years After Treatment.

Ankur Jain1, Shilpa Jain1.   

Abstract

Isolated brain metastasis (IBM) as a recurrence of primary esophageal adenocarcinoma (AC) has rarely been reported in the literature and typically manifests within a short period of time after diagnosing the primary lesion. We present here an unusual case of an IBM presenting nearly 5 years after neoadjuvant chemoradiation therapy and surgical resection of a primary distal esophageal tumor with no interval evidence of recurrence. A 53-year-old man presented to our gastroenterology clinic with progressive dysphagia and weight loss. On upper endoscopy, the patient was found to have a large obstructing distal esophageal mass with biopsies reported as moderately differentiated AC. Subsequent computed tomography (CT) chest/abdomen/pelvis (C/A/P) and magnetic resource imaging (MRI) brain were negative for any distant metastases. The patient received preoperative chemotherapy and radiation therapy, followed by distal esophagectomy with findings of stage IIIB disease. He did well after surgery and was monitored closely by his oncologist with no evidence of recurrence on interval imaging or follow-up endoscopy. Several years after his diagnosis, however, the patient developed new neurologic symptoms, and an MRI brain revealed a solitary cerebellar lesion with surrounding edema concerning for metastatic disease. Positron emission tomography and CT C/A/P were negative for any other new lesions. The tumor was resected, and pathology was confirmed as metastatic AC of esophageal origin. To our knowledge, this is the first case of recurrent esophageal AC presenting as an isolated cerebellar lesion 5 years after treatment of the primary tumor. ©Copyright 2021 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  Esophageal adenocarcinoma; isolated brain metastasis; neoadjuvant chemoradiation therapy

Mesh:

Year:  2021        PMID: 33490960      PMCID: PMC7811134     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  18 in total

1.  Incidence of brain metastasis in patients with esophageal carcinoma.

Authors:  Ron S Smith; Robert C Miller
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Esophageal carcinoma metastatic to the brain: clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy.

Authors:  T O Gabrielsen; O P Eldevik; M B Orringer; B L Marshall
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

3.  Esophageal adenocarcinoma incidence: are we reaching the peak?

Authors:  Heiko Pohl; Brenda Sirovich; H Gilbert Welch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

4.  Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.

Authors:  Tamar B Nobel; Nikita Dave; Mahmoud Eljalby; Xinxin Xing; Arianna Barbetta; Meier Hsu; Kay See Tan; Yelena Janjigian; Manjit S Bains; Smita Sihag; David R Jones; Daniela Molena
Journal:  Ann Thorac Surg       Date:  2019-10-12       Impact factor: 4.330

5.  Brain metastases from esophageal cancer: clinical review of 26 cases.

Authors:  Zhengbo Song; Baochai Lin; Lan Shao; Yiping Zhang
Journal:  World Neurosurg       Date:  2013-02-19       Impact factor: 2.104

6.  Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  F Lordick; C Mariette; K Haustermans; R Obermannová; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

Review 7.  The epidemic of oesophageal carcinoma: Where are we now?

Authors:  Aaron P Thrift
Journal:  Cancer Epidemiol       Date:  2016-02-03       Impact factor: 2.984

8.  Incidence of brain metastasis from esophageal cancer.

Authors:  G Welch; H J Ross; N P Patel; D E Jaroszewski; D E Fleischer; W G Rule; H R Paripati; F C Ramirez; J B Ashman
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

9.  Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.

Authors:  James M Donahue; Francis C Nichols; Zhuo Li; David A Schomas; Mark S Allen; Stephen D Cassivi; Aminah Jatoi; Robert C Miller; Dennis A Wigle; K Robert Shen; Claude Deschamps
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

10.  Sites of metastasis and overall survival in esophageal cancer: a population-based study.

Authors:  San-Gang Wu; Wen-Wen Zhang; Zhen-Yu He; Jia-Yuan Sun; Yong-Xiong Chen; Ling Guo
Journal:  Cancer Manag Res       Date:  2017-12-06       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.